TR200100779T2 - Yeni bir bileşim. - Google Patents
Yeni bir bileşim.Info
- Publication number
- TR200100779T2 TR200100779T2 TR2001/00779T TR200100779T TR200100779T2 TR 200100779 T2 TR200100779 T2 TR 200100779T2 TR 2001/00779 T TR2001/00779 T TR 2001/00779T TR 200100779 T TR200100779 T TR 200100779T TR 200100779 T2 TR200100779 T2 TR 200100779T2
- Authority
- TR
- Turkey
- Prior art keywords
- composition
- component
- new combination
- discomfort
- dicyclobutylamino
- Prior art date
Links
- 239000000203 mixture Substances 0.000 abstract 4
- AHOUBRCZNHFOSL-YOEHRIQHSA-N (+)-Casbol Chemical compound C1=CC(F)=CC=C1[C@H]1[C@H](COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-YOEHRIQHSA-N 0.000 abstract 1
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- 208000006558 Dental Calculus Diseases 0.000 abstract 1
- -1 N-dicyclobutylamino-8-fluoro-3,4-dihydro-2H-1-benzopyran-5-carboxamide hydrogen Chemical class 0.000 abstract 1
- AHOUBRCZNHFOSL-UHFFFAOYSA-N Paroxetine hydrochloride Natural products C1=CC(F)=CC=C1C1C(COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-UHFFFAOYSA-N 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- 230000002996 emotional effect Effects 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 239000012458 free base Substances 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 150000004682 monohydrates Chemical class 0.000 abstract 1
- 229960002296 paroxetine Drugs 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- 208000020016 psychiatric disease Diseases 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Bir ilk bilesen (a) olarak (R)-3-N, N-disiklobutilamino-8-floro-3, 4-dihidro-2H-1-benzopiran-5-karboksamid hidrojen (2R,3R)-tartar monohidrat ve bir ikinci bilesen (b) olarak serbest baz, ya da bundan dolayi eczacilikla ilgili kabul edilebilir bir tuz ve/veya eriyik formunda olan paroksetin içeren bir bilesim ile ilgilidir, bundan dolayi bahsedilen bilesimi içeren eczacilikla ilgili formüller, kullanimi ve bahsedilen bilesimi içeren teçhizat gibi, ruhsal rahatsizliklar ve endiseyle ilgili rahatsizliklar gibi duygusal rahatsizliklarin tedavisinde bir yöntemdir.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9803156A SE9803156D0 (sv) | 1998-09-16 | 1998-09-16 | A new composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR200100779T2 true TR200100779T2 (tr) | 2001-10-22 |
Family
ID=20412627
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2001/00779T TR200100779T2 (tr) | 1998-09-16 | 1999-09-13 | Yeni bir bileşim. |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1128825A1 (tr) |
| JP (1) | JP2002524508A (tr) |
| KR (1) | KR20010099647A (tr) |
| CN (1) | CN1317964A (tr) |
| AR (1) | AR021808A1 (tr) |
| AU (1) | AU6378099A (tr) |
| BR (1) | BR9913748A (tr) |
| CA (1) | CA2342341A1 (tr) |
| CZ (1) | CZ2001961A3 (tr) |
| EE (1) | EE200100157A (tr) |
| HU (1) | HUP0103544A3 (tr) |
| ID (1) | ID28785A (tr) |
| IL (1) | IL141519A0 (tr) |
| IS (1) | IS5879A (tr) |
| NO (1) | NO20011312L (tr) |
| PL (1) | PL346763A1 (tr) |
| SE (1) | SE9803156D0 (tr) |
| SK (1) | SK3262001A3 (tr) |
| TR (1) | TR200100779T2 (tr) |
| WO (1) | WO2000015218A1 (tr) |
| ZA (1) | ZA200101946B (tr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4312456B2 (ja) * | 2000-10-13 | 2009-08-12 | ニューロサーチ、アクティーゼルスカブ | ニコチン性レセプターアゴニスト及びモノアミン作動性物質の組み合わせ作用による情動障害の治療法 |
| US20090036488A1 (en) * | 2005-03-04 | 2009-02-05 | Tokyo Medical And Dental University | Recurrence preventive therapeutic agent for psychostimulant-induced psychosis and schizophrenia |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9501567D0 (sv) * | 1995-04-27 | 1995-04-27 | Astra Ab | A new combination |
-
1998
- 1998-09-16 SE SE9803156A patent/SE9803156D0/xx unknown
-
1999
- 1999-09-13 JP JP2000569802A patent/JP2002524508A/ja active Pending
- 1999-09-13 ID IDW20010581A patent/ID28785A/id unknown
- 1999-09-13 EE EEP200100157A patent/EE200100157A/xx unknown
- 1999-09-13 HU HU0103544A patent/HUP0103544A3/hu unknown
- 1999-09-13 PL PL99346763A patent/PL346763A1/xx unknown
- 1999-09-13 KR KR1020017003337A patent/KR20010099647A/ko not_active Withdrawn
- 1999-09-13 TR TR2001/00779T patent/TR200100779T2/tr unknown
- 1999-09-13 CN CN99811010A patent/CN1317964A/zh active Pending
- 1999-09-13 WO PCT/SE1999/001597 patent/WO2000015218A1/en not_active Ceased
- 1999-09-13 SK SK326-2001A patent/SK3262001A3/sk unknown
- 1999-09-13 BR BR9913748-8A patent/BR9913748A/pt not_active Application Discontinuation
- 1999-09-13 EP EP99951319A patent/EP1128825A1/en not_active Withdrawn
- 1999-09-13 CZ CZ2001961A patent/CZ2001961A3/cs unknown
- 1999-09-13 IL IL14151999A patent/IL141519A0/xx unknown
- 1999-09-13 AU AU63780/99A patent/AU6378099A/en not_active Abandoned
- 1999-09-13 CA CA002342341A patent/CA2342341A1/en not_active Abandoned
- 1999-09-15 AR ARP990104626A patent/AR021808A1/es not_active Application Discontinuation
-
2001
- 2001-03-07 IS IS5879A patent/IS5879A/is unknown
- 2001-03-08 ZA ZA200101946A patent/ZA200101946B/en unknown
- 2001-03-15 NO NO20011312A patent/NO20011312L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IS5879A (is) | 2001-03-07 |
| EE200100157A (et) | 2002-08-15 |
| IL141519A0 (en) | 2002-03-10 |
| CZ2001961A3 (cs) | 2001-08-15 |
| AU6378099A (en) | 2000-04-03 |
| WO2000015218A1 (en) | 2000-03-23 |
| HUP0103544A3 (en) | 2003-12-29 |
| SE9803156D0 (sv) | 1998-09-16 |
| KR20010099647A (ko) | 2001-11-09 |
| CN1317964A (zh) | 2001-10-17 |
| ID28785A (id) | 2001-07-05 |
| NO20011312D0 (no) | 2001-03-15 |
| CA2342341A1 (en) | 2000-03-23 |
| SK3262001A3 (en) | 2001-08-06 |
| AR021808A1 (es) | 2002-08-07 |
| BR9913748A (pt) | 2001-07-10 |
| HUP0103544A2 (hu) | 2002-05-29 |
| ZA200101946B (en) | 2002-06-10 |
| PL346763A1 (en) | 2002-02-25 |
| JP2002524508A (ja) | 2002-08-06 |
| NO20011312L (no) | 2001-05-16 |
| EP1128825A1 (en) | 2001-09-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR200102800T2 (tr) | Yeni bileşikler. | |
| TR200101398T2 (tr) | Pirolidin türevleri-CCR-3 reseptörü antagonistleri. | |
| ATE234092T1 (de) | 2-alkylpyrrolidine | |
| TR200101339T2 (tr) | Potasyum kanal modülatörleri olarak 3-yer-alanlı-4-arilkinolin-2-on türevleri, 3,4-okzadiazolon türevleri | |
| ATE245636T1 (de) | Benzofurylpiperazine: 5-ht2c serotoninrezeptor agonisten | |
| PT935465E (pt) | Compostos novos de imidazole substituido | |
| EA200100713A1 (ru) | Препаративная форма галантамина с регулируемым выделением | |
| BR9713338A (pt) | Benzonaftiridinas como terapêuticos brÈnquicos. | |
| SE9702773D0 (sv) | Novel compounds | |
| AU5186799A (en) | Peptides of il-2 and derivatives thereof and their use as therapeutic agents | |
| AU2059499A (en) | Use of heterocyclic quaternary polyammonium polymers as protective agent for keratin fibres and cosmetic compositions | |
| YU13301A (sh) | Muskarinski agonisti i antagonisti | |
| TR199900486T2 (tr) | Aziniloksi ve fenoksi-diaril-karbonasit türevleri. | |
| SE0102055D0 (sv) | New Compounds | |
| PE20010956A1 (es) | Derivados de isoquinolina y quinazolina con afinidad por los receptores de serotonina combinados 5-ht1a, 5-ht1b, 5-ht1d | |
| DE69525740D1 (de) | Spezielle halofantrinhaltige Zusammensetzungen | |
| ES2163658T3 (es) | Nueva composicion reductora y nuevo procedimiento para la deformacion permanente de los cabellos. | |
| BR9915955A (pt) | Composição cosmética para cuidado com a pele, processo cosmético para tratar uma pele envelhecida e uso de 4- cromanona | |
| DE60029954D1 (de) | Dermale anästhetika | |
| BG105710A (en) | 5ht1 antagonists for antidepressant therapy | |
| PT1107793E (pt) | Conjugados de dextrano-leptina, composicoes farmaceuticas e processos relacionados | |
| TR200100779T2 (tr) | Yeni bir bileşim. | |
| BG105539A (bg) | Елетриптан хидробромид монохидрат | |
| SE9504662D0 (sv) | New compounds | |
| BR0009194A (pt) | Composição do resorcinol |